[Treatment of multiple myeloma resistant to alkylating agents with dexamethasone, vincristine and adriamycin in continuous infusion]. - Suppr | 超能文献

[Treatment of multiple myeloma resistant to alkylating agents with dexamethasone, vincristine and adriamycin in continuous infusion].

作者信息

Monconduit M, Le Loët X, Bernard J F, Menard J F, Grosbois B, Michaux J L, De Gramont A, Laporte J P, Najman A, Jouet J P

出版信息

Rev Rhum Mal Osteoartic. 1987 Jun;54(6):477-9.

Abstract

摘要

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1

[Treatment of multiple myeloma resistant to alkylating agents with dexamethasone, vincristine and adriamycin in continuous infusion].

Rev Rhum Mal Osteoartic. 1987 Jun;54(6):477-9.

2

Effective treatment of advanced multiple myeloma refractory to alkylating agents.对烷化剂难治的晚期多发性骨髓瘤的有效治疗。

N Engl J Med. 1984 May 24;310(21):1353-6. doi: 10.1056/NEJM198405243102104.

3

Chemotherapy of resistant multiple myeloma with vincristine, adriamycin and dexamethasone (VAD).长春新碱、阿霉素和地塞米松（VAD）治疗耐药性多发性骨髓瘤

Chemioterapia. 1987 Jun;6(2 Suppl):727-8.

4

[Results of treatment of patients with advanced multiple myeloma with the vincristine-adriamycin-dexamethasone protocol].[采用长春新碱-阿霉素-地塞米松方案治疗晚期多发性骨髓瘤患者的结果]

Srp Arh Celok Lek. 1996 Nov-Dec;124(11-12):292-6.

5

[Treatment of multiple myelomas resistant to alkylating agents by continuous vincristine-adriamycin perfusion and dexamethasone. Group for the Study and Research on Myelomas].[通过持续长春新碱-阿霉素灌注及地塞米松治疗对烷化剂耐药的多发性骨髓瘤。骨髓瘤研究与研究小组]

Presse Med. 1986 Nov 15;15(40):2001-4.

6

[Lower cardiotoxicity of adriamycin during continuous administration in patients with refractory multiple myeloma treated with cyclophosphamide, vincristine, adriamycin and dexamethasone (C-VAD)].

Vnitr Lek. 1994 Aug;40(8):506-12.

7

Pegylated liposomal doxorubicin, vincristine, and dexamethasone provide significant reduction in toxicity compared with doxorubicin, vincristine, and dexamethasone in patients with newly diagnosed multiple myeloma: a Phase III multicenter randomized trial.聚乙二醇化脂质体阿霉素、长春新碱和地塞米松与阿霉素、长春新碱和地塞米松相比，可显著降低新诊断的多发性骨髓瘤患者的毒性：一项III期多中心随机试验。

Cancer. 2006 Feb 15;106(4):848-58. doi: 10.1002/cncr.21662.

8

Treatment of refractory multiple myeloma with vincristine, adriamycin, dexamethasone, and with repeated application of cyclophosphamide (C-VAD).采用长春新碱、阿霉素、地塞米松以及重复应用环磷酰胺（C-VAD）治疗难治性多发性骨髓瘤。

Acta Med Austriaca. 1994;21(4):111-5.

9

High dose simvastatin does not reverse resistance to vincristine, adriamycin, and dexamethasone (VAD) in myeloma.大剂量辛伐他汀不能逆转骨髓瘤对长春新碱、阿霉素和地塞米松（VAD）的耐药性。

Haematologica. 2007 Dec;92(12):e130-1. doi: 10.3324/haematol.12071.

10

[Ambulatory therapy of multiple myeloma with vincristine, adriamycin and dexamethasone].

Dtsch Med Wochenschr. 1997 Apr 25;122(17):531-5. doi: 10.1055/s-2008-1047649.